The voluntary action affects devices manufactured before May 12, 2025, after reports of component detachment linked to patient injuries and one death, with Olympus reinforcing safeguards to prioritise patient safety....
The bone-sparing implant, cleared for both anatomic and reverse shoulder arthroplasty, enhances surgical flexibility and patient outcomes while reinforcing the company’s leadership in shoulder care innovation....
The collaboration introduces BD Rowa™ Vmax robotic technology to deliver 24/7 prescription access, streamline pharmacy operations, and empower staff to focus on patient-centred care....
The new CLIA-waived immunoassay enables simultaneous detection of influenza A/B and SARS-CoV-2 in just 10 minutes, supporting faster, cost-effective decision-making at the point of care....
The expanded clearance extends BioTraceIO360 beyond liver applications to kidney procedures, advancing Techsomed’s vision of a multi-organ, AI-driven image-guided therapy platform that standardises minimally invasive cancer care....
The Institute, led by Dr. Shyam Sathanandam, is transforming neonatal cardiac care by delivering minimally invasive PDA closures directly in the NICU—eliminating transport risks and accelerating recovery for South Florida’s most vulnerable infants....
The Implantable Tibial Neuromodulation (ITNM) device will expand treatment options for the 16 million people living with urinary urges and involuntary leaks...
The COHERENT-AF trial will enrol up to 360 patients across clinical sites in the United States and Europe...
Together, the three devices streamline the procedure by combining effective stone treatment with rapid, controlled clearance...
The outpatient procedures were performed as part of an ongoing FDA IDE clinical trial ...
